Skip to main content
. Author manuscript; available in PMC: 2018 Jun 18.
Published in final edited form as: AAPS J. 2016 Oct 24;19(1):141–149. doi: 10.1208/s12248-016-9999-6

Fig. 3.

Fig. 3

UBM injection decreases expression of inflammatory markers 8 weeks post-ACLT. Quantitative PCR on whole joint samples at 8 weeks post UBM injection. a Cartilage-related genes. UBM-treated mice increased Aggrecan (Acan) expression compared to WT treatment. b Immune-related genes. UBM-treated IL-10 (Il10) expression compared to PBS control mice. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001